Tech Titans Aren't The Only Game In Town, Consider Biotech And, Yes, FinancialsSeeking Alpha • 05/15/23
bluebird bio Reports First Quarter 2023 Financial Results and Highlights Operational ProgressBusiness Wire • 05/09/23
Bluebird Bio (BLUE) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 05/02/23
May MDA Breakout Stocks/ETFs Week 18: High-Frequency Gainers To Give You An EdgeSeeking Alpha • 04/30/23
bluebird bio Announces First Quarter 2023 Earnings Date and Upcoming Investor EventsBusiness Wire • 04/27/23
bluebird bio Submits Biologics License Application (BLA) to FDA for lovotibeglogene autotemcel (lovo-cel) for Patients with Sickle Cell Disease (SCD) 12 years and Older with a History of Vaso-Occlusive EventsBusiness Wire • 04/24/23
After Plunging -37.53% in 4 Weeks, Here's Why the Trend Might Reverse for Bluebird (BLUE)Zacks Investment Research • 04/03/23
bluebird bio Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Operational ProgressBusiness Wire • 03/29/23
Bluebird Bio (BLUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseZacks Investment Research • 02/24/23